Company intelligence / Profile preview

Etana Biotechnologies

East Jakarta, Jakarta Special Capital Region, Indonesiaid.etanabiotech.com ↗
Ownership
Private
Employees
~500
Development stage
Commercial
01

Overview

Etana has commercialized a recombinant erythropoietin product for anemia and an mRNA-based COVID vaccine with Indonesian regulatory approval. The company’s oncology pipeline includes a bevacizumab biosimilar for advanced cancers. It aims to pioneer local biomanufacturing of biologics and vaccines for Southeast Asia.

Therapeutic areas
OncologyMetabolic DisordersImmunologyNephrologyInfectious Diseases
Modalities
mRNA vaccinesMonoclonal antibodies (mAbs)Recombinant proteinsBiosimilarsSmall molecules
Industry
Biotech
02

Drug pipeline

2 assets

bevacizumab

Commercial
Indications
Cancer

1 more asset in the full pipeline.

Request access →
03

Partnerships

Innovent Biologics – out-license agreement for bevacizumab biosimilar productionRecce Pharmaceuticals – strategic partnership on anti-infective clinical programsDEG, Yunfeng Capital, HighLight Capital, East Ventures – investors with potential strategic input

Beyond the preview

Go deeper on Etana Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Etana Biotechnologies.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call